IART (STOCKS)
Integra LifeSciences Holdings
$11.250000
+0.270000 (+2.46%)
Prev close: $10.980000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Mojdeh Poul
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $870.83M
- Employees
- 4,396
- P/E (TTM)
- -1.73
- P/B (TTM)
- 0.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.64B |
| Benefits Costs and Expenses | $2.19B |
| Cost Of Revenue | $783.14M |
| Costs And Expenses | $2.12B |
| Gross Profit | $859.83M |
| Operating Expenses | $1.34B |
| Selling, General, and Administrative Expenses | $708.95M |
| Other Operating Expenses | $631.66M |
| Operating Income/Loss | -$480.78M |
| Income/Loss From Continuing Operations After Tax | -$495.34M |
| Income/Loss From Continuing Operations Before Tax | -$545.27M |
| Income Tax Expense/Benefit | -$49.94M |
| Income Tax Expense/Benefit, Deferred | -$62.30M |
| Net Income/Loss | -$495.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$495.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$495.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.46 |
| Diluted Earnings Per Share | -$6.46 |
| Basic Average Shares | 229,725,000 |
| Diluted Average Shares | 229,725,000 |
| Assets | $3.65B |
| Current Assets | $1.14B |
| Inventory | $489.11M |
| Prepaid Expenses | $94.11M |
| Other Current Assets | $560.37M |
| Noncurrent Assets | $2.50B |
| Fixed Assets | $437.37M |
| Intangible Assets | $1.16B |
| Other Non-current Assets | $905.36M |
| Liabilities | $2.61B |
| Current Liabilities | $364.05M |
| Wages | $74.99M |
| Other Current Liabilities | $289.07M |
| Noncurrent Liabilities | $2.24B |
| Long-term Debt | $736.25M |
| Other Non-current Liabilities | $1.51B |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.04B |
| Liabilities And Equity | $3.65B |
| Net Cash Flow From Operating Activities | $89.31M |
| Net Cash Flow From Operating Activities, Continuing | $89.31M |
| Net Cash Flow From Investing Activities | -$77.41M |
| Net Cash Flow From Investing Activities, Continuing | -$77.41M |
| Net Cash Flow From Financing Activities | -$3.16M |
| Net Cash Flow From Financing Activities, Continuing | -$3.16M |
| Exchange Gains/Losses | $8.28M |
| Net Cash Flow | $17.03M |
| Net Cash Flow, Continuing | $8.75M |
| Comprehensive Income/Loss | -$502.46M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$502.46M |
| Other Comprehensive Income/Loss | -$502.46M |
| Other Comprehensive Income/Loss Attributable To Parent | -$7.12M |